Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1989. Upgrade now.
Date Value
September 30, 2024 5.714B
June 30, 2024 4.657B
March 31, 2024 2.85B
December 31, 2023 5.804B
September 30, 2023 6.522B
June 30, 2023 3.058B
March 31, 2023 2.394B
December 31, 2022 3.763B
September 30, 2022 5.332B
June 30, 2022 4.718B
March 31, 2022 3.372B
December 31, 2021 4.317B
September 30, 2021 7.543B
June 30, 2021 4.501B
March 31, 2021 3.397B
December 31, 2020 7.02B
September 30, 2020 7.646B
June 30, 2020 2.79B
March 31, 2020 2.733B
December 31, 2019 5.138B
September 30, 2019 6.782B
June 30, 2019 5.111B
March 31, 2019 2.887B
December 31, 2018 4.926B
September 30, 2018 5.453B
Date Value
June 30, 2018 5.204B
March 31, 2018 2.948B
December 31, 2017 4.865B
September 30, 2017 5.476B
June 30, 2017 5.083B
March 31, 2017 2.353B
December 31, 2016 5.56B
September 30, 2016 4.624B
June 30, 2016 3.807B
March 31, 2016 1.55B
December 31, 2015 3.719B
September 30, 2015 5.351B
June 30, 2015 4.707B
March 31, 2015 2.329B
December 31, 2014 3.108B
September 30, 2014 3.903B
June 30, 2014 4.692B
March 31, 2014 3.293B
December 31, 2013 2.71B
September 30, 2013 5.138B
June 30, 2013 4.28B
March 31, 2013 1.691B
December 31, 2012 2.224B
September 30, 2012 4.298B
June 30, 2012 3.647B

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

2.394B
Minimum
Mar 2023
7.646B
Maximum
Sep 2020
4.663B
Average
4.579B
Median

Free Cash Flow (Quarterly) Benchmarks

Amgen Inc 3.314B
Eli Lilly and Co -458.90M
Merck & Co Inc 8.508B
Pfizer Inc 6.063B
AbbVie Inc 5.198B